No evidence for alteration in early secondary mineralization by either alendronate, teriparatide or combination of both in transiliac bone biopsy samples from postmenopausal osteoporotic patients.
- DOI
- 10.1016/j.bonr.2020.100253
- Published
- 2020 Jun
- Container
- Bone reports
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bonr.2020.100253,
title = {No evidence for alteration in early secondary mineralization by either alendronate, teriparatide or combination of both in transiliac bone biopsy samples from postmenopausal osteoporotic patients.},
author = {Misof BM and Roschger P and Zhou H and Nieves JW and Bostrom M and Cosman F and Lindsay R and Klaushofer K and Dempster DW},
year = {2020},
journal = {Bone reports},
doi = {10.1016/j.bonr.2020.100253},
url = {https://doi.org/10.1016/j.bonr.2020.100253}
}RIS
TY - JOUR TI - No evidence for alteration in early secondary mineralization by either alendronate, teriparatide or combination of both in transiliac bone biopsy samples from postmenopausal osteoporotic patients. AU - Misof BM AU - Roschger P AU - Zhou H AU - Nieves JW AU - Bostrom M AU - Cosman F AU - Lindsay R AU - Klaushofer K AU - Dempster DW PY - 2020 JO - Bone reports DO - 10.1016/j.bonr.2020.100253 UR - https://doi.org/10.1016/j.bonr.2020.100253 ER -
APA
BM, M., P, R., H, Z., JW, N., M, B., F, C., R, L., K, K., & DW, D. (2020). No evidence for alteration in early secondary mineralization by either alendronate, teriparatide or combination of both in transiliac bone biopsy samples from postmenopausal osteoporotic patients.. Bone reports. https://doi.org/10.1016/j.bonr.2020.100253
Source records
- pubmed · retrieved 2026-09-26T12:04:05.425Z